Home › Rhabdomyosarcoma › Texas › Dallas
Rhabdomyosarcoma clinical trials in Dallas, TX
3 studies for Rhabdomyosarcoma are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Children's Medical Center, Dallas
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
RecruitingPhase 1
- UT Southwestern, Dallas
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
RecruitingPhase 3
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Rhabdomyosarcoma trials in other cities
- Memphis, TN6 studies
- Houston, TX5 studies
- Washington, DC5 studies
- Salt Lake City, UT4 studies
- Birmingham, AL3 studies
- Milwaukee, WI3 studies
- Philadelphia, PA3 studies
- Mountain View, CA3 studies
- The Bronx, NY3 studies
- Aurora, CO3 studies
- Boston, MA3 studies
- Baltimore, MD3 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.